The mRNA expression of the A1 astrocyte markers (C3, Fkbp5, and Serping1) was decreased, while the expression of the A2 astrocyte markers (S100a10 and Emp1) was increased in the peri-infarction tissue after intervention with miR-29a-5p agomir (Fig. 3C). The gene discussed is EMP1; the disease is infarction.